- Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments→ Danna Breen has been promoted to head of obesity discovery at Pfizer, according to a LinkedIn post. Breen succeeds Kendra Bence and gets this opportunity after nearly 14 years with ...Endpoints · 17d ago↗ source
- Roche scraps two Ionis-partnered Huntington’s drugs<p>The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal in animal…BioPharma Dive · 17d ago↗ source
- ARPA-H bookmarks $160M for custom gene editing treatments. Is it enough?After an infant last year was saved from a deadly disease thanks to a bespoke gene editing therapy that fixed an incredibly rare mutation in his DNA, the US government is hoping ...